References
- Christiansen HE, Schwarze U, Pyott SM, AlSwaid A, Al Balwi M, Alrasheed S, et al. Homozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive osteogenesis imperfecta. Am J Hum Genet 2010;86:389–98.
- Smith RJH, Shearer AE, Hildebrand MS, Van Camp G. Deafness and hereditary hearing loss overview. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, et al., editors. GeneReviews®. Seattle (WA): University of Washington; 1999:1993–2016.
- Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 1979;16:101–16.
- Glorieux FH, Ward LM, Rauch F, Lalic L, Roughley PJ, Travers R. Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect. J Bone Miner Res 2002;17:30–8.
- Glorieux FH, Rauch F, Plotkin H, Ward L, Travers R, Roughley P, et al. Type V osteogenesis imperfecta: a new form of brittle bone disease. J Bone Miner Res 2000;15:1650–8.
- Ward LM, Rauch F, Travers R, Chabot G, Azouz EM, Lalic L, et al. Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease. Bone 2002;31:12–18.
- Byers PH, Shapiro JR, Rowe DW, David KE, Holbrook KA. Abnormal alpha 2-chain in type I collagen from a patient with a form of osteogenesis imperfecta. J Clin Invest 1983;71:689–97.
- Forlino A, Marini JC. Osteogenesis imperfecta. Lancet. 2015. [Epub ahead of print]. DOI: 10.1016/S0140-6736(15)00728-X.
- Cheng SQ, Shi ZL. Advance of genetic studies and gene therapy on osteogenesis imperfecta. Int J Pediatr 2009;36:541–4.
- Valadares ER, Carneiro TB, Santos PM, Oliveira AC, Zabel B. What is new in genetics and osteogenesis imperfecta classification? J Pediatr (Rio J) 2014;90:536–41.
- Willing MC, Deschenes SP, Slayton RL, Roberts EJ. Premature chain termination is a unifying mechanism for COL1A1 null alleles in osteogenesis imperfecta type I cell strains. Am J Hum Genet 1996;59:799–809.
- Pollitt R, McMahon R, Nunn J, Bamford R, Afifi A, Bishop N, et al. Mutation analysis of COL1A1 and COL1A2 in patients diagnosed with osteogenesis imperfecta type I-IV. Hum Mutat 2006;27:716.
- Wang X, Pei Y, Dou J, Lu J, Li J, Lv Z. Identification of a novel COL1A1 frameshift mutation, c.700delG, in a Chinese osteogenesis imperfecta family. Genet Mol Biol 2015;38:1–7.
- Marini JC, Forlino A, Cabral WA, Barnes AM, San Antonio JD, Milgrom S, et al. Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum Mutat 2007;28:209–21.
- Lee KS, Song HR, Cho TJ, Kim HJ, Lee TM, Jin HS, et al. Mutational spectrum of type I collagen genes in Korean patients with osteogenesis imperfecta. Hum Mutat 2006;27:599.
- Peccarelli M, Kebaara BW. Regulation of natural mRNAs by the nonsense-mediated mRNA decay pathway. Eukaryot Cell 2014;13:1126–35.
- Fan N, Jonas JB, He F, Yan NH, Wang Y, Liu L, et al. A novel frameshift deletion in the COL1A1 gene identified in a Chinese family with osteogenesis imperfecta. Genet Mol Res 2015;14:15295–300.
- Zhao D, Yang J, Guo Z, Li R. A novel splicing mutation in COL1A1 gene caused type I osteogenesis imperfecta in a Chinese family. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2014;31:189–91.
- Zhang ZL, Zhang H, Ke YH, Yue H, Xiao WJ, Yu JB, et al. The identification of novel mutations in COL1A1, COL1A2, and LEPRE1 genes in Chinese patients with osteogenesis imperfecta. J Bone Miner Metab 2012;30:69–77.